• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK Archive

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view current FDA-TRACK performance measures and projects view the Active Index

Filter








Results

Number of results: 19

ItemProgramOfficeFY
Completed
Strategic PlanStrategic Goal/Area
1Number of OCET-coordinated meetings regarding CT and ET issues with Centers in the monthOCSOffice of Counterterrorism and Emerging Threats2011N/AN/A
2Number of external meetings (hosted by CDC, NIH, industry, and sponsors) attended by OCET to communicate agency policy on CT and ET in the monthOCSOffice of Counterterrorism and Emerging Threats2011N/AN/A
3Number of meetings to discuss Pre-Emergency Use Authorization (EUA) development in the monthOCSOffice of Counterterrorism and Emerging Threats2011N/AN/A
4Number of documents reviewed for CT and ET policy development in the monthOCSOffice of Counterterrorism and Emerging Threats2011N/AN/A
5Total number of meeting requests received through MCM.gov in the monthOCSOffice of Counterterrorism and Emerging Threats2011N/AN/A
6Number of meetings FDA attends with sponsors who requested a meeting through MCM.gov in the monthOCSOffice of Counterterrorism and Emerging Threats2011N/AN/A
7Implement MCM Initiative (MCMi)OCSOffice of Counterterrorism and Emerging Threats2012N/AN/A
8Strategic Science and Innovation PlanOCSOffice of the Chief Scientist2011N/AN/A
9Tuberculosis InitiativeOCSOffice of Regulatory Science and Innovation2011N/AN/A
10Neglected/Tropical Disease InitiativeOCSOffice of Regulatory Science and Innovation2011N/AN/A
11Modernize Toxicology TestingOCSOffice of Regulatory Science and Innovation2011N/AN/A
12Improving the Efficiency of Clinical TrialsOCSOffice of Regulatory Science and Innovation2011N/AN/A
13Health Resources and Services Administration (HRSA) Patient Safety and Clinical Pharmacy Services CollaborativeOCSOffice of Women's Health2011N/AN/A
14Video NovellaOCSOffice of Women's Health2012N/AN/A
15Modernizing ToxicologyOCSOffice of the Chief Scientist2013N/AN/A
16Broad Agency Announcement (BAA)OCSOffice of Regulatory Science and Innovation2013N/AN/A
17Number of Departmental meetings in the month related to ACA implementationACAOffice of Minority Health2013N/AN/A
18Strengthen FDA capacity to address minority health and health disparities across the AgencyACAOffice of Minority Health2013N/AN/A
19Strengthen Regulatory Science/Health Disparities Research InitiativesACAOffice of Minority Health2013N/AN/A

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.